We may use cookies to improve your experience with our website and to provide you with more relevant content based on your interests. To learn more about what information we collect, how we use it, and how to manage cookies, review our Privacy Policy.

Exact Sciences to Host Second-Quarter 2015 Results, Annual Meeting Webcasts and Calls

MADISON, Wis.(BUSINESS WIRE) Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will host webcasts and conference calls to discuss its second-quarter 2015 financial results and of its annual stockholders meeting.

Second-Quarter 2015 Webcast & Conference Call Details

    Date:         Monday, July 20, 2015
    Time:         10 a.m. ET, 9 a.m. CT
    Webcast:        

The presentation can be accessed here

    Telephone:         Domestic callers, dial 877-212-6082
              International callers, dial +1 707-287-9332
              Access code for both domestic and international callers: 84732817

Annual Meeting of Stockholders Webcast & Conference Call Details

    Date:       Thursday, July 23, 2015
    Time:       11 a.m. ET, 10 a.m. CT
    Webcast:      

The presentation can be accessed here

    Telephone:       Domestic callers, dial 877-212-6082
            International callers, dial +1 707-287-9332
            Access code for both domestic and international callers: 85062957

An archive of the webcast will be available at www.exactsciences.com. A replay of the second-quarter and annual meeting conference calls will be available by calling 855-859-2056 domestically or 404-537-3406 internationally. The access code for the replay of the second-quarter call is 84732817. The annual meeting replay can be accessed with the code 85062957. The webcasts, conference calls and replays are open to all interested parties.

About Exact Sciences Corp.

Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. The company has exclusive intellectual property protecting its noninvasive, molecular screening technology for the detection of colorectal cancer. Cologuard is included in the colorectal cancer screening guidelines of the American Cancer Society and stool DNA is included in the U.S. Multi-Society Task Force on Colorectal Cancer. For more information, please follow us on Twitter @ExactSciences or find us on Facebook.

Certain statements made in this presentation contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended that are intended to be covered by the "safe harbor" created by those sections. Forward-looking statements can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should," "could," "seek," "intend," "plan," "estimate," "anticipate" or other comparable terms. All statements other than statements of historical facts included in this presentation regarding our strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Examples of forward-looking statements include, among others, statements we make regarding expected numbers of completed and reported Cologuard tests, anticipated patient compliance rates, expected future operating results, anticipated results of our sales and marketing efforts, expectations concerning payor reimbursement and the anticipated results of our product development efforts. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: our ability to successfully and profitably market our products; the acceptance of our products by patients and health care providers; the amount and nature of competition from other cancer screening products and procedures; our ability to maintain regulatory approvals and comply with applicable regulations; our success establishing and maintaining collaborative and licensing arrangements; our ability to successfully develop new products; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10-K and our subsequently filed Quarterly Reports on Form 10-Q. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Exact Sciences Corp.
J.P. Fielder
Senior Director, Corporate Communications
608-210-5220
jpfielder@exactsciences.com

Source: Exact Sciences Corp.

Topics: Exact Sciences News

Subscribe To The Blog